Detalhe da pesquisa
1.
A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation.
Transfus Med Hemother
; 50(6): 475-490, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38089497
2.
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study.
Transfus Med Hemother
; 50(5): 403-416, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899991
3.
Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
Eur J Haematol
; 107(5): 529-542, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34270825
4.
Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials.
Eur J Haematol
; 103(3): 255-267, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231828
5.
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.
Br J Haematol
; 179(4): 586-597, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961309